請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47387
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳明汝(Ming-Ju Chen) | |
dc.contributor.author | I-Nung Huang | en |
dc.contributor.author | 黃懿儂 | zh_TW |
dc.date.accessioned | 2021-06-15T05:57:36Z | - |
dc.date.available | 2010-08-19 | |
dc.date.copyright | 2010-08-19 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-08-16 | |
dc.identifier.citation | 陳宜嫺。2000。皮膚黑色素抑制劑與保濕劑效能之研究。靜宜大學應用化學系。
陳彥伯。2004。克弗爾抑制血管緊縮素轉化酶之能力及血管緊縮素轉化酶抑制肽於大腸桿菌中之表現。台灣大學動物科學技術學系。 陳麗如。2003。發酵乳-克弗爾抗氧化性之研究。台灣大學動物科學技術學系。 許佳鳳。2005。克弗爾於皮膚特性影響之研究。台灣大學動物科學技術學系。 黃聖閔。2009。具機能性水解乳清蛋白肽之開發研究。台灣大學動物科學技術學系。 戶田登志也、小阪英樹、寺井雅一、森 英樹、辨野義己、家森幸男。2005。Lactococcus lactis subsp. cremoris FCを含有する発酵乳の健常高齢者に対する排便および糞便内菌叢に及ぼす影響。日本食品科学会誌52:243-250。 Aattouri, N., and D. Lemonnier. 1997. Production of interferon induced by Streptococcus thermophilus: role of CD4+ and CD8+ lymphocytes. Nutr. Biochem. 8:25-31. Bensoussan, M., N. Jovenin, B. Garcia, L. Vandromme, D. Jolly, O. Bouché, G. Thiéfin, and G. Cadiot. 2006. Complementary and alternative medicine use by patients with inflammatory bowel disease. 30:14-23. Bernet, M. F., D. Brassart, J. R. Neeser, and A. L. Servin. 1994. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut. 35:483-489. Blümer, N., S. Sel, S. Virna, C. C. Patrascan, S. Zimmermann, U. Herz, and H. Garn. 2007. Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin. Exp. Allergy. 37:348-357. Brunser, O., M. Haschke-Becher, M. Gotteland. 2000. Urinary excretion of D(-)-lactic acid after intake of a milk formula that contains pre or probiotics. Abstrct 27 in Proc. Latin Am. Soc. Podiatr. Res., Ushuaia, Argentina. Cerening, J., C. Bouillanne, M. Landon, and M. Desmazeaud. 1992. Isolation and characterization of exopolysaccharides from slime-forming mesophilic lactic acid bacteria. J. Dairy Sci. 75:692-699. Cushman, D. W., and H. S. Cheung. 1971. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20:1637-48. Chung, Y. W., J. H. Choi, T.-Y. Oh, C. S. Eun, and D. S. Han. 2007. Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice. Clin. Exp. Immunol. 151:182-189. CLSI. 2006. Performance Standards for Antimicrobial Disk Susceptibility Tests. 9th ed. Clinical and Laboratory Standards Institute, Wayne, PA. Cross, M., L. Stevenson, and H. Gill. 2001. Anti-allergy properties of fermented foods: an immunoregulatory mechanism of lactic acid bacteria? Int. Immunopharmacol. 1:891-901. Deveau, H., M. V. Calsteren, and S. Moineau. 2002. Effect of exopolysaccharides on phage-host interactions in Lactococcus lactis. Appl. Environ. Microbiol. 68:4364-9. Dellomonaco, C., A. Amaretti, S. Zanoni, A. Pompei, D. Matteuzzi, and M. Rossi. 2007. Fermentative production of superoxide dismutase with Kluyveromyces marxianus. J. Ind. Microbiol. Biotechnol. 34:27-34. De Simone, C., B. B. Salvadori, R. Negri, M. Ferrazzi, L. Baldinelli, and R. Vesely. 1986. The adjuvant effect of yogurt on production of gamma-interferon by Con A-stimulated human peripheral blood lymphocytes. Nutr. Rep. Int. 33:419-33. Dinis, T. C. P., V. M. C. Moadeira, and L. M. Almeida. 1994. Action of phenolic derivatives (acetaminophen, salicylte, and 5-aminosalicylate) as inhibitor of membrane lipid peroxidation and as peroxyl radical scavengers. Arch. Biochem. Biophys. 315:161-169. Duboc, P., and B. Mollet. 2001. Applications of exopolysaccharides in the dairy industry. Int. Dairy J. 11: 759-768. Enomoto, T., K. Shimizu, and S. Shimazu. 2006. Suppression of allergy development by habitual intake of fermented milk foods, evidence from an epidemiological study. Arerugi. 55:1394-99. Feleszko, W., J. Jaworska, R. D. Rha, S. Steinhausen, A. Avagyan, A. Jaudszus, B. Ahrens, D. A. Groneberg, U. Wahn, and E. Hamelmann. 2006. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin. Exp. Allergy. 37:498-505. Fiocchi., C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterol. 115:182-205. Fölster-Holst, R., B. Offick, E. Proksh, and J. Schrezenmeir. 2009. Probiotics in treatment and/or prevention of allergies. Page 243 in Nutrition and Health: Probiotics in Pediatric Medicine. S. Michail and P. M. Sherman, ed. Humana Press, Totowa, NJ. Forsythe, P., M. D. Inman, and J. Bienenstock. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am. J. Respir. Crit. Care Med. 2007. 175:561-569. Fujiwara, D., S. Inoue, H. Wakabayashi, and T. Fujii. 2004. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects of both Th1/Th2 cytokine expression and balance. Int. Arch. Allergy Immunol. 135: 205-215. Giovannini, M., C. Agostoni, E. Riva, F. Salvini, A. Ruscitto, G. V. Zuccotti, G. Radaelli, and the Felicita Study Group. 2007. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lacbacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr. Res. 62:215-220. Gobbetti, M., P. Ferranti, E. Smacchi, F. Goffredi, and F. Addeo. 2000. Inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. App. Environ. Microbiol. 66:3898-904. Haller, D., S. Blum, C. Bode, W. P. Hammes, and E. J. Schiffrin. 2000. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect. Immun. 68:752-759. Harun-ur-Rashid, M., K. Togo, M. Ueda, and T. Miyamoto. 2007. Identification and characterization of dominant lactic acid bacteria isolated from traditional fermented milk Dahi in Bangladesh. World J. Microbiol. Biotechnol. 23: 125-133. He, F., A. C. Ouwehand, E. Isolauri, H. Hashimoto, Y. Benno, and S. Salminen. 2001. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. Immunol. Med. Microbiol. 30:1604-610. He, F., H. Morita, A. C. Ouwehand, M. Hosoda, M. Hiramatsu, J. Kurisaki, E. Isolauri, Y. Benno, and S. Salminen. 2002. Stimulation of the secretion of pro-inflammatory cytokines by Bifodobacterium strains. Microbiol. Immunol. 46:781-785. Hedin, C., K. Whelan, and J. O. Lindsay. 2007. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc. Nutr. Soc. 66:307-315. Higashimura, M., B. W. Mulder-Bosman, R. Reich, T. Iwasaki, and G. W. Robijn. 2000. Solution properties of viilian, the exopolysaccharide from Lactococcus lactis subsp. cremoris SBT 0495. Biopolymers. 54:143-58. Hong, W. S., H. C. Chen, Y. P. Chen, and M. J. Chen. 2009. Effects of kefir supernatant and lactic acid bacteria isolated from kefir grain on cytokine production by macrophage. Int. Dairy J. 19:244-251. Hosono, A., J. Lee, A. Ametani, M. Natsume, M. Hirayama, T. Adachi, and S. Kaminogawa. 1997. Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4. Biosci. Biotechnol. Biochem. 61:312-316. Hougee, S., A. J. M. Vriesema, S. C. Wijering, L. M. J. Knippels, G. Folkerts, F. P. Nijkamp, J. Knol, and J. Garssen. 2009. Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. Int. Arch. Allergy Immunol. 151:107-117. Imaoka, A., and Y. Umesaki. 2009. Rationale for using of Bifidobacterium Probiotic strains-fermented milk against colitis based on animal experiments and clinicaltrials. Probiotics and antimicrobial proteins. 1:8-14. Jayanthi, V., C. S. Probert, and J. F. Mayberry. 1991. Epidemiology of inflammatory bowel disease. Q. J. Med. 78:5-12. Jin, L. Z., Y. W. Ho, N. Abdullah, M. A. Ali, and S. Jalaludin. 1996. Antagonistic effects of intestinal Lactobacillus isolates on pathogens of chicken. Lett. Appl. Microbiol. 23:67-71. Kahala, M., M. Mäki, A. Lehtovaara, J. M. Tapanaien, R. Katiska, M. Juuruskorpi, J. Juhola, and V. Joutsjoki. 2008. Characterization of starter lactic acid bacteria from the Finnish fermented milk product viili. J. Appl. Microbiol. 105:1929-1938. Kawase, M., F. He, A. Kubota, M. Hiramatsu, H. Saito, T. Ishii, H. Yasueda, and K. Akiyama. 2009. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study. Int. J. Food Microbiol. 128:429-434. Kato, I., K. Tanaka, and T. Yokokura. 1999. Lactic acid bacterium potently induces the production of interleukin-12 and interferon- | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47387 | - |
dc.description.abstract | 台灣黏質發酵乳 (Taiwanese ropy fermented milk, TRFM) 由本研究室保存,含有可分泌胞外多醣體 (exopolysaccharide, EPS) 之乳酸菌,其質地黏稠類似芬蘭傳統發酵乳viili,因此TRFM又稱作Taiwanese viili。本研究室過去以聚合酶連鎖反應-變性梯度膠體電泳 (polymerase chain reaction-denaturing gradient gel electrophoresis, PCR-DGGE) 配合16s rDNA定序方法鑑定TRFM中四株乳酸菌 (Lactococcus lactis subsp. cremoris TL1, TL3, TL4 and Leuconostoc mesenteroides TL2) 及三株酵母菌 (Kluyveromyces marxianus TY1, Pichia fermentans TY2 and Saccharomyces unisporus TY3)。本研究之目的為進一步評估TRFM及其分離菌株之機能性,包括抗氧化、美容功能、抑制血管緊縮素轉化酶 (angiotensin-converting enzyme, ACE) 及免疫調節機能評估。
為了解TRFM之抗氧化能力,試驗中檢測亞鐵離子、銅離子的螯合能力及DPPH自由基的清除力。TRFM上清液之DPPH清除力隨著發酵時間增加,但其亞鐵離子和銅離子的螯合力與對照組沒有顯著差異。在美容功能部分,TRFM上清液對於黑色素催化酵素酪胺酸酶的抑制力低於50%,且與兩種痤瘡病原菌共培養均沒有抑菌效果。ACE為人體調控血壓之重要酵素,在臨床治療上,抑制ACE的活性可治療高血壓。本試驗檢測TRFM上清液對ACE的抑制效果,發現隨著發酵時間增長,其ACE抑制力越高。 至於免疫調節的部分,胞外試驗的結果顯示TRFM及其分離菌株可刺激小鼠巨噬細胞株RAW 264.7和小鼠脾臟細胞分泌促發炎反應細胞激素、TH1細胞激素和多效性細胞激素IL-10,表示TRFM具有免疫調控之潛力。將TRFM及菌株餵予致敏小鼠,可抑制總IgE及過敏原特異IgE在血清中的濃度,且不同菌株改善過敏的途徑不同;餵予致結腸炎小鼠,則可改善糞便出血評分,結腸長度顯著增加。 由以上結果可得知TRFM及分離菌株具有不同面向之機能性。除了在過敏及結腸炎的動物模式中有顯著的改善效果,其抗氧化和ACE的抑制能力仍未經動物試驗證實,且其有效成分及作用機制仍待進一步研究。 | zh_TW |
dc.description.abstract | Taiwanese ropy fermented milk (TRFM) is a milk product with a ropy and sticky consistency, caused by slime-forming lactic acid bacteria (LAB) in the starter cultures producing exopolysacchrides (EPS). Since the texture and flavor of TRFM are similar to that of traditional Finnish fermented milk viili, we also call it “Taiwanese viili”. Four LAB strains (Lactococcus lactis subsp. cremoris TL1, TL3, TL4 and Leuconostoc mesenteroides TL2) and three yeast strains (Kluyveromyces marxianus TY1, Pichia fermentans TY2 and Saccharomyces unisporus TY3) have been isolated and identified previously in our lab by polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE). The purpose of this study was to further investigate the functional properties of TRFM and the microorganisms, including antioxidation, angiotensin converting enzyme (ACE) inhibition, in vitro immunoregulation, anti-allergic and anti-colitis effects in murine model.
For antioxidative activities of TRFM, three methods including ferrous ion chelating, cupric ion chelating, and DPPH free radical scavenging were conducted. Results indicated that TRFM supernatant showed significant activities of scavenging DPPH free radical with a fermentation time manner but showed no any chelating ion ability. ACE is known to associate with hypertension and congestive heart failure. The TRFM samples demonstrated a significantly higher inhibition in ACE. For the immunoregulatory effects, TRFM samples and the microorganisms were co-cultured with murine macrophage cell line RAW 264.7 and murine splenocyte in vitro. TRFM samples and the LAB strains induced the production of TH1 cytokine TNF-alpha | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T05:57:36Z (GMT). No. of bitstreams: 1 ntu-99-R97626010-1.pdf: 8591138 bytes, checksum: 0f63bd376be81f07bb61ef2ba3941826 (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 口試委員會審定書
誌謝 ……………………………………………………………… i 序言 ……………………………………………………………… iii 中文摘要 ………………………………………………………… iv 英文摘要 ………………………………………………………… vi 第一章 文獻檢討 ……………………………………………… 1 一、黏質發酵乳 ………………………………………………… 1 (一)Viilii ………………………………………………… 3 (二)台灣黏質發酵乳 ………………………………………… 6 二、乳酸菌用於減緩過敏之機能性探討 ……………………… 7 (一)過敏之起因 ……………………………………………… 7 (二)過敏機制簡介 …………………………………………… 7 (三)乳酸菌減緩過敏之機制探討 …………………………… 10 (四)乳酸菌減緩過敏之潛力 ………………………………… 14 三、乳酸菌用於減緩潰瘍性結腸炎之機能性探討 …………… 19 (一)IBD之病因及特徵 ………………………………………… 19 (二)乳酸菌減緩潰瘍性結腸炎之潛力 ……………………… 23 第二章 材料與方法 …………………………………………… 27 第一部分:TRFM之抗氧化、美容功能及抑制ACE機能評估 27 第二部分:TRFM及其微生物之免疫調節機能評估………… 32 第三章 結果與討論 …………………………………………… 41 第一部分:TRFM之抗氧化、美容功能及抑制ACE機能評估 41 一、抗氧化能力測定 ………………………………… 41 二、美容功能測定 …………………………………… 45 三、抑制ACE活性測定 ……………………………… 49 第二部分:TRFM及其微生物之免疫調節機能評估 ……… 51 一、免疫細胞體外試驗 ……………………………… 51 二、致敏小鼠動物試驗 ……………………………… 67 三、結腸炎小鼠動物試驗 …………………………… 78 第四章 結論 …………………………………………………… 87 參考文獻 ………………………………………………………… 89 作者小傳 ………………………………………………………… 106 | |
dc.language.iso | zh-TW | |
dc.title | 台灣黏質發酵乳之機能性研究 | zh_TW |
dc.title | Investigation on functional properties of Taiwanese ropy fermented milk | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 林慶文(Chin-Wen Lin),劉?睿(Je-Ruei Liu),陳小玲(Hsiao-Ling Chen),黃英豪 | |
dc.subject.keyword | 台灣黏質發酵乳,抗氧化,過敏,結腸炎, | zh_TW |
dc.subject.keyword | TRFM,antioxidation,allergy,colitis, | en |
dc.relation.page | 106 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2010-08-18 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 動物科學技術學研究所 | zh_TW |
顯示於系所單位: | 動物科學技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 8.39 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。